243 related articles for article (PubMed ID: 28618875)
21. Comparison of inhaled long-acting β-agonist and anticholinergic effectiveness in older patients with chronic obstructive pulmonary disease: a cohort study.
Gershon A; Croxford R; To T; Stanbrook MB; Upshur R; Sanchez-Romeu P; Stukel T
Ann Intern Med; 2011 May; 154(9):583-92. PubMed ID: 21536937
[TBL] [Abstract][Full Text] [Related]
22. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
Hanania NA
Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
[TBL] [Abstract][Full Text] [Related]
23. Sex differences in inappropriate prescribing among elderly veterans.
Bierman AS; Pugh MJ; Dhalla I; Amuan M; Fincke BG; Rosen A; Berlowitz DR
Am J Geriatr Pharmacother; 2007 Jun; 5(2):147-61. PubMed ID: 17719517
[TBL] [Abstract][Full Text] [Related]
24. Trend of cost and utilization of COPD medication in Korea.
Lee J; Lee JH; Kim JA; Rhee CK
Int J Chron Obstruct Pulmon Dis; 2017; 12():27-33. PubMed ID: 28031708
[TBL] [Abstract][Full Text] [Related]
25. Outcomes associated with tiotropium use in patients with chronic obstructive pulmonary disease.
Lee TA; Wilke C; Joo M; Stroupe KT; Krishnan JA; Schumock GT; Pickard AS
Arch Intern Med; 2009 Aug; 169(15):1403-10. PubMed ID: 19667304
[TBL] [Abstract][Full Text] [Related]
26. Non-persistence and non-adherence to long-acting COPD medication therapy: A retrospective cohort study based on a large German claims dataset.
Mueller S; Wilke T; Bechtel B; Punekar YS; Mitzner K; Virchow JC
Respir Med; 2017 Jan; 122():1-11. PubMed ID: 27993284
[TBL] [Abstract][Full Text] [Related]
27. Using Big Data to Assess Prescribing Patterns in Greece: The Case of Chronic Obstructive Pulmonary Disease.
Souliotis K; Kani C; Papageorgiou M; Lionis D; Gourgoulianis K
PLoS One; 2016; 11(5):e0154960. PubMed ID: 27191724
[TBL] [Abstract][Full Text] [Related]
28. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
29. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study.
Wurst KE; Shukla A; Muellerova H; Davis KJ
COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236
[TBL] [Abstract][Full Text] [Related]
30. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial.
Singh D; Papi A; Corradi M; Pavlišová I; Montagna I; Francisco C; Cohuet G; Vezzoli S; Scuri M; Vestbo J
Lancet; 2016 Sep; 388(10048):963-73. PubMed ID: 27598678
[TBL] [Abstract][Full Text] [Related]
31. Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments.
Trudo F; Kern DM; Davis JR; Tunceli O; Zhou S; Graham EL; Strange C; Williams SA
Int J Chron Obstruct Pulmon Dis; 2015; 10():2055-66. PubMed ID: 26451101
[TBL] [Abstract][Full Text] [Related]
32. Bronchodilators use in patients with COPD.
Dong YH; Hsu CL; Li YY; Chang CH; Lai MS
Int J Chron Obstruct Pulmon Dis; 2015; 10():1769-79. PubMed ID: 26366069
[TBL] [Abstract][Full Text] [Related]
33. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD).
Cecere LM; Slatore CG; Uman JE; Evans LE; Udris EM; Bryson CL; Au DH
COPD; 2012 Jun; 9(3):251-8. PubMed ID: 22497533
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and Therapeutic Gaps in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease.
Canepa M; Franssen FME; Olschewski H; Lainscak M; Böhm M; Tavazzi L; Rosenkranz S
JACC Heart Fail; 2019 Oct; 7(10):823-833. PubMed ID: 31521680
[TBL] [Abstract][Full Text] [Related]
35. Long-acting bronchodilators with or without inhaled corticosteroids and 30-day readmission in patients hospitalized for COPD.
Bishwakarma R; Zhang W; Kuo YF; Sharma G
Int J Chron Obstruct Pulmon Dis; 2017; 12():477-486. PubMed ID: 28203071
[TBL] [Abstract][Full Text] [Related]
36. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
37. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society.
Qaseem A; Wilt TJ; Weinberger SE; Hanania NA; Criner G; van der Molen T; Marciniuk DD; Denberg T; Schünemann H; Wedzicha W; MacDonald R; Shekelle P; ; ; ;
Ann Intern Med; 2011 Aug; 155(3):179-91. PubMed ID: 21810710
[TBL] [Abstract][Full Text] [Related]
38. The comparative effectiveness of initiating fluticasone/salmeterol combination therapy via pMDI versus DPI in reducing exacerbations and treatment escalation in COPD: a UK database study.
Jones R; Martin J; Thomas V; Skinner D; Marshall J; Stagno d'Alcontres M; Price D
Int J Chron Obstruct Pulmon Dis; 2017; 12():2445-2454. PubMed ID: 28860739
[TBL] [Abstract][Full Text] [Related]
39. Benzodiazepine and sedative-hypnotic use among older seriously Ill veterans: choosing wisely?
Garrido MM; Prigerson HG; Penrod JD; Jones SC; Boockvar KS
Clin Ther; 2014 Nov; 36(11):1547-54. PubMed ID: 25453732
[TBL] [Abstract][Full Text] [Related]
40. Variation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysis.
Fitch K; Iwasaki K; Pyenson B; Plauschinat C; Zhang J
Curr Med Res Opin; 2011 Jul; 27(7):1425-9. PubMed ID: 21599554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
